Base to Base biotech podcast 68: Water from air for pharma and beyond
New phase 1 data show potential for neurodegenerative disease treatment
Metabolic syndrome linked to faster brain ageing
Bowel cancer samples could boost understanding of other killer diseases
Aukera Therapeutics emerges from stealth
FDA clears allogeneic CAR-T recurrent glioblastoma therapy for phase II trial
Platform to test new cancer treatments
Potential biomarker for targeted psoriasis therapy discovered
Base to Base biotech podcast 40: Anchored immunotherapy, and healing the skin
Sobi boosts gout battle with Arthrosi Therapeutics acquisition
Immune ‘switch’ is potential target to curb chronic inflammation in cirrhosis
InnoCare to move to phase 3 after achieving SLE endpoints